Skip to main content
logo
Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.73
+7.37 (1.95%)
At close: Jul 28, 2026, 4:00 PM EDT
385.50
-0.23 (-0.06%)
After-hours: Jul 28, 2026, 7:39 PM EDT

Elevance Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Cap
83,65383,85963,63577,37571,74487,43898,17083,917120,588125,658120,584109,907102,280104,791109,027122,065108,563115,819118,453112,075
Market Cap Growth (YoY)
28.50%-4.09%-35.18%-7.80%-40.51%-30.42%-18.59%-23.65%17.90%19.91%10.60%-9.96%-5.79%-9.52%-7.96%8.91%19.94%24.36%34.73%42.23%
Enterprise Value
104,46577,52858,54473,45067,75982,96194,63880,579109,907117,459110,87098,75788,34591,73896,427111,97496,486105,669107,722102,146
Last Close Price
385.73386.73292.75350.55323.12388.96434.96368.90520.00541.86518.54471.56435.42444.29459.81512.97454.24482.58491.22463.54

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
17.1617.1912.4513.9113.2116.5516.9714.3718.9619.0019.6018.7017.3316.8918.2221.1317.9519.4519.3918.58
Forward PE
14.2414.7311.2813.0910.5210.9912.6011.2513.1214.1413.9713.1712.5513.2314.0216.1414.8916.2817.2516.70
PEG Ratio
3.913.832.2714.531.331.281.241.251.091.761.171.111.031.201.181.261.241.161.401.17
PS Ratio
0.420.420.320.390.370.470.540.480.700.740.710.650.610.640.680.780.710.780.830.82
PB Ratio
1.861.871.451.761.632.002.312.032.752.982.972.802.662.742.923.373.023.233.293.11
P/TBV Ratio
15.3315.1514.4417.9217.3122.7346.1190.3116.2021.8730.7429.9238.9947.4294.3680.08102.44171.98105.6893.51
P/FCF Ratio
13.3013.339.8724.3819.0516.3826.7218.44138.45153.2452.5216.2512.409.919.8016.8410.4414.4416.3115.40
P/OCF Ratio
11.2111.248.3718.0414.6113.5520.2514.4556.5960.7933.7813.6310.758.868.8414.539.3712.6314.1013.40

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
0.520.390.300.370.350.440.520.460.640.690.650.580.530.560.600.720.630.710.750.75
EV/EBITDA Ratio
15.7911.728.078.838.019.7010.729.1311.8512.2011.6310.969.459.3010.0512.183.634.104.3012.13
EV/EBIT Ratio
21.3015.8110.5911.189.7911.7312.7911.0713.9914.4814.0012.9711.6911.4112.3414.903.864.354.5514.35
EV/FCF Ratio
16.6112.339.0823.1417.9915.5425.7617.70126.19143.2448.2914.6010.718.688.6715.459.2813.1714.8314.04

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.680.680.720.700.710.650.670.710.570.590.580.600.620.660.680.620.600.590.560.59
Debt / EBITDA Ratio
4.6915.3813.6842.7321.1211.368.8635.0516.819.428.1916.8512.618.858.3316.249.609.178.764.03
Debt / FCF Ratio
4.9419.097.77-41.4216.8936.5481.3311.58223.2715.57-10.8315.704.13-5.1510.9410.1717.29
Net Debt / Equity Ratio
-0.14-0.14-0.12-0.09-0.09-0.10-0.09-0.08-0.25-0.20-0.24-0.29-0.37-0.34-0.34-0.28-0.34-0.28-0.30-0.28
Net Debt / EBITDA Ratio
-0.98-3.20-2.25-5.42-2.71-1.73-1.08-3.87-6.68-2.83-3.04-7.54-7.13-4.63-4.15-6.85-4.90-3.97-4.06-1.75
Net Debt / FCF Ratio
-1.03-3.98-1.2819.47-5.31-2.58-4.44-8.98-4.60-66.98-5.783.41-6.12-8.22-2.065.61-2.63-4.73-4.72-7.50
Asset Turnover
0.400.400.400.410.420.420.420.400.390.390.380.400.400.410.400.400.390.390.390.39
Quick Ratio
1.381.381.321.411.431.321.311.321.341.321.231.301.291.321.311.271.211.221.231.33
Current Ratio
1.521.521.481.541.561.441.431.451.501.491.371.441.411.441.431.401.351.361.361.47
Return on Equity (ROE)
3.27%3.27%4.06%1.28%2.70%4.05%5.24%1.02%2.45%5.71%5.75%2.19%3.49%5.00%5.45%2.42%4.45%4.61%5.09%3.40%
Return on Assets (ROA)
1.00%1.00%1.23%0.31%0.80%1.48%2.03%0.30%0.83%1.81%2.01%0.84%1.14%1.74%1.90%0.85%1.51%1.70%1.81%4.66%
Return on Invested Capital (ROIC)
3.21%3.21%3.83%0.92%2.42%4.43%6.12%0.95%2.81%6.18%7.52%3.36%4.89%7.33%7.80%3.39%6.14%6.59%6.90%16.90%
Return on Capital Employed (ROCE)
2.06%2.06%2.51%0.18%1.45%3.05%4.17%0.69%1.82%3.75%4.31%1.64%2.40%3.73%4.06%1.61%3.25%3.52%3.78%8.93%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jul '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
5.93%5.82%8.03%7.19%7.57%6.04%5.89%6.96%5.27%5.26%5.10%5.35%5.77%5.92%5.49%4.73%5.57%5.14%5.16%5.38%
FCF Yield
7.52%7.50%10.14%4.10%5.25%6.10%3.74%5.42%0.72%0.65%1.90%6.16%8.06%10.09%10.21%5.94%9.58%6.93%6.13%6.49%
Dividend Yield
1.78%0.44%0.58%0.48%0.53%0.44%0.39%0.44%0.31%0.30%0.31%0.31%0.34%0.33%0.32%0.25%0.28%0.27%0.26%0.24%
Payout Ratio
30.57%25.50%21.32%68.92%32.04%22.09%17.68%89.23%37.20%16.43%16.87%40.42%27.00%18.89%17.65%35.26%19.09%18.88%17.27%22.92%
Buyback Yield / Dilution
3.64%3.50%2.99%4.02%4.03%3.26%2.99%1.99%1.44%1.85%2.29%2.24%2.35%2.30%1.92%1.75%1.54%1.62%1.53%2.23%
Total Shareholder Return
5.43%3.94%3.58%4.51%4.56%3.70%3.38%2.43%1.75%2.15%2.61%2.55%2.69%2.63%2.24%2.00%1.83%1.88%1.79%2.47%
SEC Filings: 10-K · 10-Q